Free Trial
$100 Off Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 Now
Claim MarketBeat All Access Sale Promotion

Yuanbao (YB) Competitors

Yuanbao logo
$12.70 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$12.82 +0.13 (+0.98%)
As of 05/22/2026 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

YB vs. FIHL, SLDE, PLGO, SKWD, and CLOV

Should you buy Yuanbao stock or one of its competitors? MarketBeat compares Yuanbao with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Yuanbao include Fidelis Insurance (FIHL), Slide Insurance (SLDE), Fidelis Insurance (PLGO), Skyward Specialty Insurance Group (SKWD), and Clover Health Investments (CLOV). These companies are all part of the "insurance" industry.

How does Yuanbao compare to Fidelis Insurance?

Yuanbao (NASDAQ:YB) and Fidelis Insurance (NYSE:FIHL) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.

Yuanbao currently has a consensus target price of $21.80, suggesting a potential upside of 71.65%. Fidelis Insurance has a consensus target price of $21.92, suggesting a potential downside of 3.83%. Given Yuanbao's higher probable upside, analysts clearly believe Yuanbao is more favorable than Fidelis Insurance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Yuanbao
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Fidelis Insurance
2 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.13

Yuanbao has a net margin of 29.89% compared to Fidelis Insurance's net margin of 9.02%. Yuanbao's return on equity of 68.51% beat Fidelis Insurance's return on equity.

Company Net Margins Return on Equity Return on Assets
Yuanbao29.89% 68.51% 32.78%
Fidelis Insurance 9.02%8.62%1.62%

In the previous week, Fidelis Insurance had 2 more articles in the media than Yuanbao. MarketBeat recorded 3 mentions for Fidelis Insurance and 1 mentions for Yuanbao. Fidelis Insurance's average media sentiment score of 0.99 beat Yuanbao's score of 0.00 indicating that Fidelis Insurance is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Yuanbao
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Fidelis Insurance
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

82.0% of Fidelis Insurance shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Fidelis Insurance has higher revenue and earnings than Yuanbao. Yuanbao is trading at a lower price-to-earnings ratio than Fidelis Insurance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yuanbao$625.35M0.92$181.88M$3.873.28
Fidelis Insurance$2.17B1.01$225.50M$2.2110.31

Summary

Fidelis Insurance beats Yuanbao on 9 of the 14 factors compared between the two stocks.

How does Yuanbao compare to Slide Insurance?

Slide Insurance (NASDAQ:SLDE) and Yuanbao (NASDAQ:YB) are both insurance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

Slide Insurance has a net margin of 38.86% compared to Yuanbao's net margin of 29.89%. Yuanbao's return on equity of 68.51% beat Slide Insurance's return on equity.

Company Net Margins Return on Equity Return on Assets
Slide Insurance38.86% 48.38% 17.38%
Yuanbao 29.89%68.51%32.78%

Slide Insurance presently has a consensus target price of $24.80, indicating a potential upside of 33.12%. Yuanbao has a consensus target price of $21.80, indicating a potential upside of 71.65%. Given Yuanbao's higher probable upside, analysts plainly believe Yuanbao is more favorable than Slide Insurance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Slide Insurance
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.89
Yuanbao
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Slide Insurance had 30 more articles in the media than Yuanbao. MarketBeat recorded 31 mentions for Slide Insurance and 1 mentions for Yuanbao. Slide Insurance's average media sentiment score of 0.19 beat Yuanbao's score of 0.00 indicating that Slide Insurance is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Slide Insurance
15 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Yuanbao
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Slide Insurance has higher revenue and earnings than Yuanbao. Yuanbao is trading at a lower price-to-earnings ratio than Slide Insurance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Slide Insurance$1.16B1.85$443.96M$3.605.18
Yuanbao$625.35M0.92$181.88M$3.873.28

Summary

Slide Insurance beats Yuanbao on 10 of the 14 factors compared between the two stocks.

How does Yuanbao compare to Fidelis Insurance?

Fidelis Insurance (NYSE:PLGO) and Yuanbao (NASDAQ:YB) are both small-cap insurance companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, risk, analyst recommendations and valuation.

Fidelis Insurance currently has a consensus target price of $25.00, suggesting a potential upside of 9.56%. Yuanbao has a consensus target price of $21.80, suggesting a potential upside of 71.65%. Given Yuanbao's higher possible upside, analysts clearly believe Yuanbao is more favorable than Fidelis Insurance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fidelis Insurance
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Yuanbao
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

82.0% of Fidelis Insurance shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Fidelis Insurance has higher revenue and earnings than Yuanbao. Yuanbao is trading at a lower price-to-earnings ratio than Fidelis Insurance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fidelis Insurance$2.50B0.79$225.50M$3.746.10
Yuanbao$625.35M0.92$181.88M$3.873.28

Yuanbao has a net margin of 29.89% compared to Fidelis Insurance's net margin of 15.33%. Yuanbao's return on equity of 68.51% beat Fidelis Insurance's return on equity.

Company Net Margins Return on Equity Return on Assets
Fidelis Insurance15.33% 14.44% 2.63%
Yuanbao 29.89%68.51%32.78%

In the previous week, Fidelis Insurance had 2 more articles in the media than Yuanbao. MarketBeat recorded 3 mentions for Fidelis Insurance and 1 mentions for Yuanbao. Fidelis Insurance's average media sentiment score of 0.18 beat Yuanbao's score of 0.00 indicating that Fidelis Insurance is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fidelis Insurance
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Yuanbao
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Fidelis Insurance beats Yuanbao on 8 of the 14 factors compared between the two stocks.

How does Yuanbao compare to Skyward Specialty Insurance Group?

Yuanbao (NASDAQ:YB) and Skyward Specialty Insurance Group (NASDAQ:SKWD) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

Yuanbao currently has a consensus target price of $21.80, suggesting a potential upside of 71.65%. Skyward Specialty Insurance Group has a consensus target price of $65.75, suggesting a potential upside of 38.57%. Given Yuanbao's higher possible upside, equities analysts plainly believe Yuanbao is more favorable than Skyward Specialty Insurance Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Yuanbao
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Skyward Specialty Insurance Group
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.80

94.8% of Skyward Specialty Insurance Group shares are held by institutional investors. 8.5% of Skyward Specialty Insurance Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Yuanbao has a net margin of 29.89% compared to Skyward Specialty Insurance Group's net margin of 11.36%. Yuanbao's return on equity of 68.51% beat Skyward Specialty Insurance Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Yuanbao29.89% 68.51% 32.78%
Skyward Specialty Insurance Group 11.36%18.24%3.69%

In the previous week, Skyward Specialty Insurance Group had 3 more articles in the media than Yuanbao. MarketBeat recorded 4 mentions for Skyward Specialty Insurance Group and 1 mentions for Yuanbao. Skyward Specialty Insurance Group's average media sentiment score of 1.52 beat Yuanbao's score of 0.00 indicating that Skyward Specialty Insurance Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Yuanbao
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Skyward Specialty Insurance Group
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Yuanbao has higher earnings, but lower revenue than Skyward Specialty Insurance Group. Yuanbao is trading at a lower price-to-earnings ratio than Skyward Specialty Insurance Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yuanbao$625.35M0.92$181.88M$3.873.28
Skyward Specialty Insurance Group$1.57B1.23$170.03M$4.1511.43

Summary

Skyward Specialty Insurance Group beats Yuanbao on 11 of the 16 factors compared between the two stocks.

How does Yuanbao compare to Clover Health Investments?

Yuanbao (NASDAQ:YB) and Clover Health Investments (NASDAQ:CLOV) are both small-cap insurance companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Yuanbao has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Yuanbao, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yuanbao$625.35M0.92$181.88M$3.873.28
Clover Health Investments$1.92B0.97-$85.55M-$0.12N/A

Yuanbao currently has a consensus price target of $21.80, suggesting a potential upside of 71.65%. Clover Health Investments has a consensus price target of $2.90, suggesting a potential downside of 18.31%. Given Yuanbao's higher probable upside, equities analysts plainly believe Yuanbao is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Yuanbao
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Yuanbao has a net margin of 29.89% compared to Clover Health Investments' net margin of -2.58%. Yuanbao's return on equity of 68.51% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Yuanbao29.89% 68.51% 32.78%
Clover Health Investments -2.58%-16.52%-9.28%

In the previous week, Clover Health Investments had 4 more articles in the media than Yuanbao. MarketBeat recorded 5 mentions for Clover Health Investments and 1 mentions for Yuanbao. Clover Health Investments' average media sentiment score of 0.29 beat Yuanbao's score of 0.00 indicating that Clover Health Investments is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Yuanbao
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Clover Health Investments
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

19.8% of Clover Health Investments shares are held by institutional investors. 23.5% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Yuanbao and Clover Health Investments tied by winning 7 of the 14 factors compared between the two stocks.

Get Yuanbao News Delivered to You Automatically

Sign up to receive the latest news and ratings for YB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding YB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

YB vs. The Competition

MetricYuanbaoINS IndustryFinance SectorNASDAQ Exchange
Market Cap$572.52M$21.09B$13.57B$12.32B
Dividend YieldN/A3.00%5.84%5.28%
P/E Ratio3.2810.4723.9625.66
Price / Sales0.921.56150.32111.99
Price / Cash1.9911.1020.1556.67
Price / Book1.232.182.157.14
Net Income$181.88M$1.86B$1.13B$335.98M
7 Day Performance-11.25%-1.38%0.61%3.56%
1 Month Performance-24.09%0.36%-0.07%2.54%
1 Year Performance-15.28%3.57%12.01%35.05%

Yuanbao Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
YB
Yuanbao
2.8223 of 5 stars
$12.70
flat
$21.80
+71.7%
-15.3%$572.52M$625.35M3.28497
FIHL
Fidelis Insurance
3.1302 of 5 stars
$23.06
-0.8%
$21.92
-5.0%
+38.8%$2.23B$2.17B10.4377
SLDE
Slide Insurance
4.454 of 5 stars
$18.63
+0.1%
$24.80
+33.1%
N/A$2.13B$1.16B5.18392
PLGO
Fidelis Insurance
4.0383 of 5 stars
$22.82
-1.0%
$25.00
+9.6%
N/A$1.99B$2.50B6.10N/A
SKWD
Skyward Specialty Insurance Group
4.9401 of 5 stars
$47.45
+1.0%
$65.75
+38.6%
-22.2%$1.91B$1.42B11.43400

Related Companies and Tools


This page (NASDAQ:YB) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners